| Note |
Make a choice, Serenace (haloperidol) Timeless efficacy, Matchless safety. More than 3 decades of clinical experience. Olanzapine has no clinically significant advantage over haloperidol. Haloperidol demonstrates greater improvement in quality of life scale and symptom scores as compared to Olanzapine. Olanzapine increases the risk of diabetes. Olanzapine is associated with metabolic deregulation leading to diabetes, dramatic weight gain and atherogenic lipid profile. Available in a wide range. Dosage convenience. Uncooperative patients. Rapid neuroleptisation. Sustained benefits. |
